CHRS Operating Income
Coherus Oncology Inc · Operating Income
CHRS Operating Income
Latest reported-$156.60Mperiod ending
CHRS TTM Operating Income (-$35.99M → -$156.60M)
TTM operating income
High-resolution chart · PNG
CHRS operating income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Income (USD) |
|---|---|
| -156,595,000 | |
| -169,750,000 | |
| -179,034,000 | |
| -175,400,000 | |
| -139,554,000 | |
| -114,577,000 | |
| -136,929,000 | |
| -163,588,000 | |
| -189,207,000 | |
| -203,241,000 | |
| -203,199,000 | |
| -185,787,000 | |
| -234,230,000 | |
| -243,700,000 | |
| -256,880,000 | |
| -244,934,000 | |
| -197,272,000 | |
| -177,423,000 | |
| -263,858,000 | |
| -207,886,000 | |
| -141,383,000 | |
| -51,909,000 | |
| 156,319,000 | |
| 184,927,000 | |
| 203,052,000 | |
| 165,235,000 | |
| 107,768,000 | |
| 2,233,000 | |
| -106,580,000 | |
| -178,983,000 | |
| -204,416,000 | |
| -190,380,000 | |
| -190,023,000 | |
| -201,751,000 | |
| -232,136,000 | |
| -259,130,000 | |
| -117,898,000 | |
| -123,996,000 | |
| -115,931,000 | |
| -94,678,000 | |
| -250,512,000 | |
| -246,671,000 | |
| -219,067,000 | |
| -193,420,000 | |
| -128,626,000 | |
| -87,669,000 | |
| -64,682,000 | |
| -48,609,000 | |
| -48,969,000 | |
| -40,315,000 | |
| -35,993,000 |